Tirzepatide: indication and product status matter

Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.

Certain branded tirzepatide medicines are FDA approved for specific labeled uses. Compounded tirzepatide is not FDA approved, and other unapproved versions have not been reviewed as complete products for safety, effectiveness, or quality. A clinician and pharmacist can help verify the product and its authorized use.